These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 19637245)
1. Anxiety and distress during active surveillance for early prostate cancer. van den Bergh RC; Essink-Bot ML; Roobol MJ; Wolters T; Schröder FH; Bangma CH; Steyerberg EW Cancer; 2009 Sep; 115(17):3868-78. PubMed ID: 19637245 [TBL] [Abstract][Full Text] [Related]
2. Do anxiety and distress increase during active surveillance for low risk prostate cancer? van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064 [TBL] [Abstract][Full Text] [Related]
3. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels. Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075 [TBL] [Abstract][Full Text] [Related]
4. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer. Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894 [TBL] [Abstract][Full Text] [Related]
5. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485 [TBL] [Abstract][Full Text] [Related]
6. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272 [TBL] [Abstract][Full Text] [Related]
7. Psychological distress in Japanese men with localized prostate cancer. Namiki S; Saito S; Tochigi T; Numata I; Ioritani N; Arai Y Int J Urol; 2007 Oct; 14(10):924-9. PubMed ID: 17880290 [TBL] [Abstract][Full Text] [Related]
8. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. Latini DM; Hart SL; Knight SJ; Cowan JE; Ross PL; Duchane J; Carroll PR; J Urol; 2007 Sep; 178(3 Pt 1):826-31; discussion 831-2. PubMed ID: 17632144 [TBL] [Abstract][Full Text] [Related]
9. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Roth AJ; Rosenfeld B; Kornblith AB; Gibson C; Scher HI; Curley-Smart T; Holland JC; Breitbart W Cancer; 2003 Jun; 97(11):2910-8. PubMed ID: 12767107 [TBL] [Abstract][Full Text] [Related]
10. Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Rosenfeld B; Roth AJ; Gandhi S; Penson D Psychooncology; 2004 Nov; 13(11):800-7. PubMed ID: 15386638 [TBL] [Abstract][Full Text] [Related]
11. The measurement of psychological distress in men being investigated for the presence of prostate cancer. Awsare NS; Green JS; Aldwinckle B; Hanbury DC; Boustead GB; McNicholas TA Prostate Cancer Prostatic Dis; 2008; 11(4):384-9. PubMed ID: 18427569 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Davison BJ; Oliffe JL; Pickles T; Mroz L Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342 [TBL] [Abstract][Full Text] [Related]
13. Confidence in the ability to communicate with physicians among low-income patients with prostate cancer. Maliski SL; Kwan L; Krupski T; Fink A; Orecklin JR; Litwin MS Urology; 2004 Aug; 64(2):329-34. PubMed ID: 15302489 [TBL] [Abstract][Full Text] [Related]
14. Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group Study 5. Jønler M; Nielsen OS; Groenvold M; Hedlund PO; Damber L; Hedelin H; Waldén M; Scand J Urol Nephrol; 2005; 39(1):42-8. PubMed ID: 15764270 [TBL] [Abstract][Full Text] [Related]
15. Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role. Hack TF; Pickles T; Ruether JD; Weir L; Bultz BD; Mackey J; Degner LF Psychooncology; 2010 Jun; 19(6):606-16. PubMed ID: 19557823 [TBL] [Abstract][Full Text] [Related]
16. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor. Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018 [TBL] [Abstract][Full Text] [Related]
17. Regret in men treated for localized prostate cancer. Hu JC; Kwan L; Saigal CS; Litwin MS J Urol; 2003 Jun; 169(6):2279-83. PubMed ID: 12771770 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322 [TBL] [Abstract][Full Text] [Related]
19. Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study. Kornblith AB; Dowell JM; Herndon JE; Engelman BJ; Bauer-Wu S; Small EJ; Morrison VA; Atkins J; Cohen HJ; Holland JC Cancer; 2006 Dec; 107(11):2706-14. PubMed ID: 17078057 [TBL] [Abstract][Full Text] [Related]
20. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland. Hegarty JM; Wallace M; Comber H Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]